Trial intelligence / Profile preview

Bupivacaine plus adrenaline versus bupivacaine plus neostigmine for spinal anesthesia in TURP surgery

IRCT20190715044224N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Aug 2019
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, double-blind trial of bupivacaine, epinephrine and neostigmine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Pain on visual analogue scale. Started Aug 2019; status: completed.

02

Drugs

bupivacaineepinephrineneostigmine
03

Conditions

benign prostatic hyperplasia (BPH)

Beyond the preview

Go deeper on IRCT20190715044224N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190715044224N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call